Patent details

Basic Information

Publication number:

92595

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP057047656

Legal Status:

Invalid

Application number:

92595

First applicant's nationality:

Procedural language:

French

Marketing Authorization

Marketing Authorization Number:

EU/1/14/924 - OLYSIO - siméprévir

Marketing Authorization Type:

Marketing Authorization Date:

16/05/2014

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Dates

Filing date:

11/11/2014

First Marketing Authorization date:

16/05/2014

Grant date:

02/11/2015

Activation date:

Publication date:

02/11/2015

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

16/05/2029

SPC Extension Expiration:

16/05/2029

Rejection date:

Withdrawal date:

Owner

From:

11/11/2014

 

 

Name:

MEDIVIR AB

Address:

BLASIEHOLMSGATAN 2, 111 48 STOCKHOLM, Sweden (SE)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

11/11/2014

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

ROSENQUIST Asa, c/o Medivir AB

Address:

Sweden (SE)

2

Name:

KVARNSTRÖM Ingemar, c/o IFM Faculty

Address:

Sweden (SE)

3

Name:

WALLBERG Hans, c/o Medivir AB

Address:

Sweden (SE)

4

Name:

SAMUELSSON Bertil, c/o Medivir AB

Address:

Sweden (SE)

5

Name:

JOHANSSON Per-Ola, c/o IFM Faculty

Address:

Sweden (SE)

6

Name:

THORSTENSSON Fredrik, c/o IFM Faculty

Address:

Sweden (SE)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages